Ignite Creation Date:
2024-05-05 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00134030
Status:
COMPLETED
Last Update Posted:
2023-06-07
First Post:
2005-08-22
Brief Title:
Combination Chemotherapy PEG-Interferon Alfa-2b and Surgery in Treating Patients With Osteosarcoma
Sponsor:
Childrens Oncology Group
Organization:
Childrens Oncology Group
Organization Data
Organization:
Childrens Oncology Group
Class:
NETWORK
Study ID:
AOST0331 EURAMOS-1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Childrens Oncology Group
Lead Sponsor Class:
NETWORK
Responsible Party:
Babasola Sola Popoola
Responsible Party Title:
Matthew Sydes Professor of Clinical Trials and Methodology
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
University College London
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Medical Research Council | OTHER_GOV |
| National Cancer Institute NCI | NIH |
| University College London | OTHER |